Therapeutic Usefulness of Propoxyphene Napsylate in Narcotic Addiction
- 1 February 1977
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 34 (2) , 227-233
- https://doi.org/10.1001/archpsyc.1977.01770140117013
Abstract
• The maximum doses of propoxyphene napsylate used to treat heroin addicts produce a degree of morphine-like activity equal to that produced by 20 to 25 mg/day of subcutaneously given morphine or 10 mg/day orally given methadone. This degree of activity would be sufficient to ameliorate abstinence even in patients dependent on large doses of narcotics—an observation that supports the utility of propoxyphene napsylate in detoxification. On the other hand, only patients taking 10 mg/day or less of parenterally administered heroin could be maintained on maximum subtoxic levels of propoxyphene napsylate without abstinence signs or symptoms suggesting that propoxyphene napsylate would be less useful in maintenance therapy.Keywords
This publication has 5 references indexed in Scilit:
- Heroin DetoxificationJAMA, 1975
- Naltrexone, an Antagonist for the Treatment of Heroin DependenceArchives of General Psychiatry, 1973
- Acute toxicity of propoxyphene saltsToxicology and Applied Pharmacology, 1971
- Analgesia scores as timed responses following oral administration of propoxyphene to postpartum patientsToxicology and Applied Pharmacology, 1971
- Studies of the dependence‐producing properties of GPA‐1657, profadol, and propiram in manClinical Pharmacology & Therapeutics, 1971